Skip to content
Back to all tools

Enjamb

Agentic platform for biopharma R&D and drug development

API
Jack Phillips
Audited by Jack Phillips · Updated June 2026
Visit site

Overall score

2.4/ 5
SME fit2/5
tiered pricing with step cliff + freemium
JTBD4/5
solid named JTBD
Integration3/5
API
Trust2/5
new (<12mo), founded 2023
Quality1/5
no public rating
Compliance2/5
compliance unknown

About

Enjamb provides a platform for biopharma research and development, managing the entire drug program lifecycle. It synthesizes clinical evidence, designs trials, and drafts regulatory documents, aiming to reduce the time from preclinical stages to market.

Best for: Biopharma R&D teams needing to accelerate drug development processes

Pricing

  • Free

    Monthly
    Free
    Annual /mo
    Free
    Billing
    flat
    Notes
    Powerful agent use;Unlimited projects;1 GB storage
  • Pro

    Monthly
    $20
    Annual /mo
    $20
    Billing
    flat
    Notes
    3x usage included;Unlimited projects;30 GB storage · Billed annually
  • Max

    Monthly
    $40
    Annual /mo
    $40
    Billing
    flat
    Notes
    5x usage included;Everything in Pro;100 GB storage · Billed annually
  • Lab

    Monthly
    $40
    Annual /mo
    $40
    Billing
    linear_per_seat
    Notes
    5x usage per seat;200 GB pooled storage;Central billing + admin/member roles · Billed annually
  • Enterprise

    Monthly
    n/a
    Annual /mo
    n/a
    Billing
    custom
    Notes
    Everything in Lab;Unlimited usage;SSO & SAML;Dedicated support

Key features

  • Automated literature reviews across 250 million+ papers
  • End-to-end statistical analysis with 150+ pre-installed packages
  • Integrated grant discovery and proposal drafting
  • Native editing in Word and LaTeX with 700+ templates

Trust & compliance

Stage range
MVP → Seed
Founded
2023
Status
active
SOC 2
unknown
GDPR
unknown
Data residency
unknown
External rating
n/a
Last verified
Jun 2026

Reviews

Be the first to share your experience.

Pairs well with